It is also worth noting that IL-32 is expressed by regulatory or senescent/exhausted T cells in MM, although if/how this affects the function of the T-cells and if it contributes to disease progression is not known (Bailur et al., 2019; Zavidij et al., 2020). Here, IL32 is linked to Miyoshi myopathy.